Chemotherapy Chairs Sales

Chemotherapy Chairs Sales Market Outlook

The global chemotherapy chairs market is projected to reach approximately USD 1.2 billion by 2033, expanding at a remarkable compound annual growth rate (CAGR) of 6.5% from 2025 to 2033. This promising growth trajectory is primarily driven by the increasing prevalence of cancer cases worldwide, which necessitates an upsurge in cancer treatment facilities and the demand for specialized treatment equipment such as chemotherapy chairs. Additionally, the rising awareness regarding the comfort and safety of patients undergoing chemotherapy has led healthcare providers to invest in ergonomically designed chairs that cater specifically to the needs of cancer patients. Furthermore, technological advancements in the design and functionality of chemotherapy chairs have enhanced patient experience and improved workflow efficiency for medical staff. The ongoing innovation in the healthcare sector, particularly in oncology, is expected to bolster the market's expansion over the forecast period.

Growth Factor of the Market

One of the significant growth factors contributing to the chemotherapy chairs market is the rising incidence of cancer globally. With cancer becoming one of the leading causes of death worldwide, healthcare systems are under pressure to enhance their treatment protocols, which includes providing better patient care through specialized furniture. Moreover, the advancement in design technology resulting in more comfortable and adjustable chemotherapy chairs has attracted healthcare providers. The growing trend towards outpatient treatment options has also fueled demand for chemotherapy chairs in ambulatory surgical settings and homecare environments. As more patients opt for treatments that minimize hospital stays, the need for suitable furniture becomes crucial. Furthermore, an increase in government and private funding for cancer care improvement initiatives is expected to enhance the availability and affordability of high-quality chemotherapy chairs across various healthcare facilities.

Key Highlights of the Market

• The global chemotherapy chairs market is anticipated to grow at a CAGR of 6.5% from 2025 to 2033.
• The rising prevalence of cancer is significantly driving demand for chemotherapy chairs.
• Technological advancements in chair designs are enhancing patient comfort and operational efficiency.
• Outpatient treatment trends are increasing the need for chemotherapy chairs in various settings.
• Government initiatives and funding are supporting improvements in cancer care infrastructure.

By Product Type

Electric Chemotherapy Chairs:

Electric chemotherapy chairs are becoming increasingly popular in healthcare settings due to their ease of use and patient comfort. These chairs feature electric adjustments that allow medical staff to easily modify the height, recline angle, and position with a simple push of a button. This not only enhances patient comfort during lengthy chemotherapy sessions but also facilitates better access for healthcare providers, ensuring that they can deliver care efficiently. The convenience of electric functions is particularly valuable in busy clinical environments where time is of the essence. Additionally, these chairs often come equipped with features such as built-in heating and massage options, further improving the overall patient experience. As healthcare facilities continue to prioritize patient-centered care, the demand for electric chemotherapy chairs is expected to rise significantly over the forecast period.

Hydraulic Chemotherapy Chairs:

Hydraulic chemotherapy chairs are another essential segment within the market, widely appreciated for their stability and adjustability. Utilizing hydraulic mechanisms, these chairs can be easily adjusted to suit various patient needs, allowing for smooth transitions between different positions. This is particularly important in chemotherapy, where patients may require frequent adjustments for comfort during treatment. Hydraulic chairs are typically equipped with robust suspension systems, enabling them to accommodate patients of different sizes while ensuring safety and comfort. Their durable construction makes them suitable for heavy usage in hospitals and cancer treatment centers. As healthcare facilities continue to look for reliable and sturdy options in chemotherapy chairs, hydraulic models are likely to maintain a significant share of the market.

Manual Chemotherapy Chairs:

Manual chemotherapy chairs offer a cost-effective solution for healthcare providers looking to optimize their expenditure while still providing essential comfort to patients. These chairs, while lacking the advanced features of electric or hydraulic chairs, are designed to be user-friendly and straightforward to operate. The manual adjustment mechanisms allow healthcare providers to customize the chair position according to patient needs, which can be particularly beneficial in smaller clinics or facilities with budget constraints. Furthermore, manual chemotherapy chairs often have a more compact design, making them easier to maneuver in tight spaces. As the demand for affordable yet functional medical equipment continues to rise, manual chemotherapy chairs will likely maintain a steady presence in the market.

Pediatric Chemotherapy Chairs:

Pediatric chemotherapy chairs are specifically designed to cater to the unique needs of children undergoing cancer treatment. These chairs prioritize comfort and safety, incorporating features such as adjustable seating and supportive headrests to accommodate the smaller stature of pediatric patients. The design often includes vibrant colors and themes to create a more welcoming environment for young patients, mitigating anxiety associated with treatment. Pediatric chemotherapy chairs are often used in specialized oncology units within hospitals and cancer treatment centers. Given the increasing focus on pediatric cancer care, the demand for these chairs is expected to grow significantly, as healthcare providers strive to create a more supportive experience for young patients and their families.

Bariatric Chemotherapy Chairs:

Bariatric chemotherapy chairs address the specific needs of overweight or obese patients, ensuring comfort and safety during treatment. These chairs are engineered to provide enhanced weight capacity while maintaining stability and durability. Features often include wider seats, reinforced structures, and easy-to-clean materials that facilitate hygiene and comfort. The growing prevalence of obesity globally has made it essential for healthcare providers to accommodate all patient sizes effectively. As awareness of obesity-related health issues continues to rise, the demand for bariatric chairs in chemotherapy settings will likely increase, reflecting a more inclusive approach to patient care.

By Application

Hospitals:

Hospitals represent a primary application segment for chemotherapy chairs, as they are central hubs for cancer treatment and care. In hospitals, chemotherapy chairs must meet stringent safety and operational standards, providing comfort for patients during extended treatment sessions. Given the high volume of patients treated within hospital oncology departments, these chairs are often designed for durability and ease of maintenance. Hospitals typically invest in a variety of chemotherapy chair types, including electric and hydraulic models, to support different treatment settings, such as inpatient and outpatient care. The continuous rise in cancer cases and the corresponding expansion of hospital oncology services are expected to drive significant demand within this application segment.

Clinics:

Clinics serve as vital points of care where chemotherapy chairs play a crucial role in facilitating outpatient treatment sessions. These settings often prioritize cost-effective and multifunctional chairs that can accommodate a diverse patient demographic. The design of chemotherapy chairs in clinics often focuses on maximizing space efficiency, providing flexible configurations that allow for quick adjustments as needed. Clinics typically cater to patients who prefer less intensive treatment environments and may offer more personalized care experiences. As more patients seek outpatient therapy options, the demand for high-quality chemotherapy chairs in clinical settings is expected to rise significantly.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) play an essential role in providing chemotherapy treatments to patients who do not require extended hospital stays. In these facilities, chemotherapy chairs are designed to optimize patient comfort while ensuring quick turnover rates. Given the typically shorter treatment sessions in ASCs, the chairs used in these environments often prioritize easy accessibility and mobility for both patients and healthcare providers. The growth of ASCs as cost-effective alternatives to traditional hospital settings is expected to bolster the demand for chemotherapy chairs in the coming years. Additionally, the emphasis on patient-centered care in these facilities aligns well with the features offered by modern chemotherapy chairs.

Cancer Treatment Centers:

Dedicated cancer treatment centers are specialized facilities focused on providing comprehensive oncology care, including chemotherapy administration. Within these centers, chemotherapy chairs must meet the unique needs of cancer patients, offering features that enhance comfort during lengthy treatment sessions. These facilities invest in high-quality chairs that facilitate an inviting atmosphere, vital for patient well-being. The increasing number of patients seeking specialized treatment at cancer centers is expected to drive demand for advanced chemotherapy chairs, particularly those equipped with ergonomic and adaptive features. As cancer centers evolve to provide holistic care, the importance of comfortable treatment environments will remain paramount.

Homecare Settings:

The rise of homecare settings for chemotherapy treatments has expanded the market for chemotherapy chairs significantly. Patients increasingly prefer receiving treatments in their home environments as it offers convenience and comfort, prompting healthcare providers to seek suitable furniture solutions. Chemotherapy chairs designed for homecare emphasize portability and ease of use while ensuring they meet safety standards. These chairs often include features that allow for convenient adjustments without requiring complex mechanisms. As the trend towards home-based healthcare continues to grow, the demand for homecare chemotherapy chairs is anticipated to flourish, reflecting an important shift in patient care preferences.

By Distribution Channel

Direct Sales:

Direct sales represent a pivotal distribution channel in the chemotherapy chairs market, allowing manufacturers to establish close relationships with healthcare providers. Through direct sales, companies can offer personalized consultations, ensuring that their products meet specific facility requirements and comply with industry standards. This channel is particularly advantageous for large healthcare organizations that require bulk purchases and ongoing support for their equipment needs. Direct sales also enable manufacturers to gather feedback from end-users, fostering continuous product improvement. As healthcare facilities prioritize tailored solutions, direct sales are expected to maintain a robust presence in the chemotherapy chairs market.

Distributor Sales:

Distributor sales play a significant role in the chemotherapy chairs market, providing a broader reach to various healthcare settings. Distributors are essential in supplying medical equipment to hospitals, clinics, and other facilities that may not engage directly with manufacturers. They often possess valuable knowledge about local market trends and can provide specialized customer service. Additionally, distributor sales can facilitate access to a wider range of products, including accessories and replacement parts, enhancing the overall value proposition for healthcare providers. As the demand for chemotherapy chairs continues to rise, the distributor sales channel will remain an important means of distribution for manufacturers.

By Material Type

Metal Chemotherapy Chairs:

Metal chemotherapy chairs are favored for their durability and strength, making them suitable for high-traffic healthcare settings. These chairs often feature sturdy metal frames that are able to withstand heavy usage while ensuring patient safety and comfort. The materials used in metal chemotherapy chairs are typically easy to clean, which is crucial for maintaining hygiene in healthcare environments. Additionally, metal chairs can be designed with a modern aesthetic, appealing to healthcare facilities striving to create inviting spaces for patients. As hospitals and treatment centers continue to prioritize durability and safety, the demand for metal chemotherapy chairs is expected to remain strong.

Plastic Chemotherapy Chairs:

Plastic chemotherapy chairs are an increasingly popular option due to their lightweight and versatile nature. These chairs are often designed to be easy to move and rearrange, particularly important in facilities that require flexible treatment areas. Plastic materials are resistant to stains and easy to clean, making them ideal for environments where hygiene is paramount. Furthermore, plastic chemotherapy chairs can be produced in a variety of colors and designs, allowing healthcare facilities to create a more welcoming atmosphere for patients. As the focus on patient experience grows, the market for plastic chemotherapy chairs is likely to expand significantly.

Wood Chemotherapy Chairs:

Wood chemotherapy chairs are often chosen for their aesthetic appeal and warmth, creating a more comfortable environment for patients. These chairs can be designed to complement the overall décor of healthcare facilities, contributing to a calming atmosphere. While wood offers a natural look, it also requires careful treatment to ensure durability and ease of cleaning. Many healthcare providers appreciate the option of wood chairs for their ability to convey a sense of care and compassion, which is especially important in oncology settings. As the demand for aesthetically pleasing healthcare environments rises, the market for wood chemotherapy chairs is anticipated to grow.

Others:

The "Others" segment in material types includes chemotherapy chairs made from alternative materials such as composite materials or innovative plastics that combine various properties for enhanced functionality. These options are often developed to address specific needs in patient comfort and safety. For example, some newer materials may offer improved cushioning properties or better weight distribution, enhancing the overall experience for patients undergoing treatment. As technology advances and material science continues to evolve, the demand for chemotherapy chairs utilizing alternative materials is expected to increase, reflecting ongoing innovations in the healthcare industry.

By Region

The North America region holds a substantial share of the global chemotherapy chairs market, driven by advanced healthcare infrastructure, high cancer prevalence rates, and significant investments in oncology care. The U.S. accounts for a significant portion of this market, demonstrating a CAGR of approximately 7% over the forecast period due to the increasing number of cancer cases and rising healthcare expenditure. The presence of leading medical device manufacturers and a focus on innovative healthcare solutions further solidify North America's dominance in the chemotherapy chairs market. Additionally, the growing trend towards outpatient treatment options is expected to continue propelling demand in this region.

In Europe, the chemotherapy chairs market is also witnessing steady growth, supported by the increasing awareness of cancer treatment options and advancements in medical technologies. Countries such as Germany, France, and the UK are leading contributors to this market segment, with a strong emphasis on improving patient care and comfort. The demand for chemotherapy chairs in Europe is expected to grow in tandem with the rising number of cancer treatment centers and outpatient facilities. Additionally, ongoing government initiatives aimed at enhancing healthcare access and affordability in cancer care will likely contribute to the expansion of the chemotherapy chairs market across European nations.

Opportunities

As the global chemotherapy chairs market continues to expand, several opportunities are emerging, particularly in the realm of technological integration. Manufacturers are increasingly exploring the incorporation of smart technologies into chemotherapy chairs, such as monitoring systems that track patient vital signs, comfort levels, or treatment progress. This integration of technology not only enhances patient safety and care but also provides healthcare providers with valuable data that can be used to improve treatment outcomes. The shift toward telemedicine and homecare solutions further amplifies this opportunity, as smart chemotherapy chairs can be integrated into home environments, allowing for remote monitoring and support for patients undergoing treatment at home.

Moreover, the growing emphasis on personalized medicine presents an opportunity for customization in chemotherapy chair design. Healthcare providers are becoming more aware of the unique needs of diverse patient populations, including pediatric and bariatric patients. Manufacturers can seize this opportunity by developing specialized chairs tailored to various demographics, ensuring that all patients receive optimal comfort and support during their treatment. By fostering collaboration with healthcare providers to understand their needs and challenges, manufacturers can develop innovative solutions that enhance patient care, ultimately leading to sustained market growth.

Threats

One of the primary threats facing the chemotherapy chairs market is the ongoing pressure on healthcare budgets due to rising costs associated with medical care. As healthcare facilities strive to maintain profitability while providing high-quality patient care, there may be reluctance to invest in new or upgraded chemotherapy chairs. This budgetary constraint could hinder the growth of the market, particularly in regions where funding for cancer care is limited. Additionally, the emergence of alternative treatment options, such as oral chemotherapy and immunotherapy, which may require less specialized furniture, poses a potential challenge to the demand for traditional chemotherapy chairs.

Another significant threat is the increasing competition from both established manufacturers and new entrants in the chemotherapy chairs market. As the market continues to grow, more companies are entering the space, leading to price competition and potentially compromising product quality. It is crucial for existing players to leverage their reputation, technological advancements, and innovation to differentiate themselves in this crowded marketplace. Furthermore, economic fluctuations and global supply chain disruptions, as observed during the COVID-19 pandemic, can impact production and distribution, posing risks to overall market stability.

Competitor Outlook

• Hill-Rom Holdings, Inc.
• Invacare Corporation
• Graham-Field Health Products, Inc.
• Medline Industries, Inc.
• Joerns Healthcare, LLC
• Drive DeVilbiss Healthcare
• American Bed Company
• Arjo Medical Devices
• Champion Healthcare
• Alimed, Inc.
• GE Healthcare
• Huntleigh Healthcare
• Häfele GmbH & Co. KG
• ProMed Specialties
• Bestcare Medical

The competitive landscape of the chemotherapy chairs market is characterized by a mix of established players and emerging manufacturers. Major companies are focusing on innovation, product differentiation, and expanding their distribution networks to maintain their competitive edge. In addition, they are investing in research and development to create technologically advanced chairs that enhance patient comfort and safety. Collaborations and partnerships with healthcare facilities are also becoming increasingly common, allowing manufacturers to gain valuable insights into the specific needs of end-users, thereby informing product development and marketing strategies. As the market continues to expand, companies that can effectively balance innovation and cost-effectiveness will likely flourish.

Notable players such as Hill-Rom Holdings, Inc., and Invacare Corporation have positioned themselves as leaders in the chemotherapy chairs market due to their extensive product offerings and established brand reputation. Hill-Rom, for instance, is recognized for its innovative medical technology solutions, including advanced chemotherapy chairs that offer electric adjustments and patient monitoring capabilities. Similarly, Invacare is known for its focus on ergonomically designed medical equipment that prioritizes patient comfort while ensuring durability. Both companies are actively pursuing strategies to enhance their product lines and cater to the growing demand for specialized chemotherapy chairs.

Medline Industries, Inc. is also a key player in the market, offering a wide range of chemotherapy chairs tailored to various healthcare settings. The company emphasizes its commitment to providing high-quality and innovative solutions, which has garnered a loyal customer base among hospitals and outpatient facilities. Additionally, companies like Drive DeVilbiss Healthcare and Joerns Healthcare are making strides in the chemotherapy chairs market by expanding their portfolios and improving the overall patient care experience. As competition intensifies, these organizations are likely to continue to invest in product development, ensuring they remain at the forefront of the chemotherapy chairs market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Alimed, Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 GE Healthcare
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Bestcare Medical
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 ProMed Specialties
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Champion Healthcare
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 American Bed Company
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Arjo Medical Devices
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Huntleigh Healthcare
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Invacare Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Joerns Healthcare, LLC
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Hill-Rom Holdings, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Medline Industries, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Drive DeVilbiss Healthcare
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Häfele GmbH & Co. KG
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Graham-Field Health Products, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Chemotherapy Chairs Sales Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Ambulatory Surgical Centers
    • 6.1.4 Cancer Treatment Centers
    • 6.1.5 Homecare Settings
  • 6.2 Chemotherapy Chairs Sales Market, By Product Type
    • 6.2.1 Electric Chemotherapy Chairs
    • 6.2.2 Hydraulic Chemotherapy Chairs
    • 6.2.3 Manual Chemotherapy Chairs
    • 6.2.4 Pediatric Chemotherapy Chairs
    • 6.2.5 Bariatric Chemotherapy Chairs
  • 6.3 Chemotherapy Chairs Sales Market, By Material Type
    • 6.3.1 Metal Chemotherapy Chairs
    • 6.3.2 Plastic Chemotherapy Chairs
    • 6.3.3 Wood Chemotherapy Chairs
    • 6.3.4 Others
  • 6.4 Chemotherapy Chairs Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Chemotherapy Chairs Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Chemotherapy Chairs Sales market is categorized based on

By Product Type

• Electric Chemotherapy Chairs
• Hydraulic Chemotherapy Chairs
• Manual Chemotherapy Chairs
• Pediatric Chemotherapy Chairs
• Bariatric Chemotherapy Chairs

By Application

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Cancer Treatment Centers
• Homecare Settings

By Distribution Channel

• Direct Sales
• Distributor Sales

By Material Type

• Metal Chemotherapy Chairs
• Plastic Chemotherapy Chairs
• Wood Chemotherapy Chairs
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Hill-Rom Holdings, Inc.
• Invacare Corporation
• Graham-Field Health Products, Inc.
• Medline Industries, Inc.
• Joerns Healthcare, LLC
• Drive DeVilbiss Healthcare
• American Bed Company
• Arjo Medical Devices
• Champion Healthcare
• Alimed, Inc.
• GE Healthcare
• Huntleigh Healthcare
• Häfele GmbH & Co. KG
• ProMed Specialties
• Bestcare Medical